162 related articles for article (PubMed ID: 19582372)
1. Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model.
Lange TS; Stuckey AR; Robison K; Kim KK; Singh RK; Raker CA; Brard L
Invest New Drugs; 2010 Oct; 28(5):543-53. PubMed ID: 19582372
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model.
Lange TS; Zou Y; Singh RK; Kim KK; Kristjansdottir K; Sholler GL; Brard L
Chem Biol Drug Des; 2010 Aug; 76(2):164-73. PubMed ID: 20492445
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma.
Lange TS; Singh RK; Kim KK; Zou Y; Kalkunte SS; Sholler GL; Swamy N; Brard L
Chem Biol Drug Des; 2007 Oct; 70(4):302-10. PubMed ID: 17937776
[TBL] [Abstract][Full Text] [Related]
4. Iron(III)-salophene: an organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells.
Lange TS; Kim KK; Singh RK; Strongin RM; McCourt CK; Brard L
PLoS One; 2008 May; 3(5):e2303. PubMed ID: 18509533
[TBL] [Abstract][Full Text] [Related]
5. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.
Brard L; Lange TS; Robison K; Kim KK; Ara T; McCallum MM; Arnold LA; Moore RG; Singh RK
Gynecol Oncol; 2011 Nov; 123(2):370-8. PubMed ID: 21803404
[TBL] [Abstract][Full Text] [Related]
7. A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.
Singh RK; Lange TS; Kim KK; Shaw SK; Brard L
Gynecol Oncol; 2008 May; 109(2):240-9. PubMed ID: 18329084
[TBL] [Abstract][Full Text] [Related]
8. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the potential anticancer activity of different vitamin D metabolites on colorectal and breast cancer cell lines.
Khriesha A; Bustanji Y; Abu Farha R; Al-Abbasi R; Abu-Irmaileh B
Horm Mol Biol Clin Investig; 2021 Feb; 42(1):3-9. PubMed ID: 33544505
[TBL] [Abstract][Full Text] [Related]
10. Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.
Zillhardt M; Park SM; Romero IL; Sawada K; Montag A; Krausz T; Yamada SD; Peter ME; Lengyel E
Clin Cancer Res; 2011 Jun; 17(12):4042-51. PubMed ID: 21551255
[TBL] [Abstract][Full Text] [Related]
11. Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
Stuckey A; Fischer A; Miller DH; Hillenmeyer S; Kim KK; Ritz A; Singh RK; Raphael BJ; Brard L; Brodsky AS
BMC Cancer; 2011 Jul; 11():308. PubMed ID: 21781307
[TBL] [Abstract][Full Text] [Related]
12. CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells.
Lee JC; Chou LC; Huang CH; Chung JG; Huang LJ; Lee KH; Hung MC; Way TD; Kuo SC
Eur J Pharmacol; 2011 Nov; 670(1):96-104. PubMed ID: 21907193
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation.
Park GY; Pathak HB; Godwin AK; Kwon Y
Cell Oncol (Dordr); 2021 Feb; 44(1):77-92. PubMed ID: 32910411
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model.
Moore RG; Lange TS; Robinson K; Kim KK; Uzun A; Horan TC; Kawar N; Yano N; Chu SR; Mao Q; Brard L; DePaepe ME; Padbury JF; Arnold LA; Brodsky A; Shen TL; Singh RK
PLoS One; 2012; 7(4):e34443. PubMed ID: 22509304
[TBL] [Abstract][Full Text] [Related]
15. Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.
Zhang B; Wang X; Cai F; Chen W; Loesch U; Zhong XY
Oncol Rep; 2013 Apr; 29(4):1371-8. PubMed ID: 23338561
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol Combined With Platinum-based Chemotherapy Suppresses Growth and Expression of Vascular Endothelial Growth Factor of SKOV-3 Ovarian Cancer Cells.
Kim JH; Park WH; Suh DH; Kim K; No JH; Kim YB
Anticancer Res; 2021 Jun; 41(6):2945-2952. PubMed ID: 34083285
[TBL] [Abstract][Full Text] [Related]
17. The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell.
Chen X; Chen Y; Lin X; Su S; Hou X; Zhang Q; Tian Y
Curr Pharm Biotechnol; 2018; 19(6):506-513. PubMed ID: 30003858
[TBL] [Abstract][Full Text] [Related]
18. Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells.
Fan LL; Chen X; Zhang XY; Li ZM; Fan XM; Shen Y
Med Sci Monit; 2020 Aug; 26():e922612. PubMed ID: 32829374
[TBL] [Abstract][Full Text] [Related]
19. Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
Garrett LA; Growdon WB; Rueda BR; Foster R
J Ovarian Res; 2016 Sep; 9(1):58. PubMed ID: 27633667
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.
Han X; Chen H; Zhou J; Steed H; Postovit LM; Fu Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30049957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
